论文信息 - A randomized phase 2 study comparing EC or CMF versus nab‐paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high‐risk early breast cancer (ICE II‐GBG 52) - 字舞流文

A randomized phase 2 study comparing EC or CMF versus nab‐paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high‐risk early breast cancer (ICE II‐GBG 52)

C. Denkert | W. Eiermann | F. Marmé | S. Loibl | N. Burchardi | V. Nekljudova | G. von Minckwitz | J. Huober | C. Jackisch | C. Thomssen | E. Stickeler | T. Reimer | H. Eidtmann | T. Decker | V. Möbus | B. Conrad | J. Hackmann | J. Potenberg | J. Alfer | E. Simon